- Home
- RADX vs AIXI Comparison
RADX vs AIXI Comparison
Compare RADX & AIXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RADX
- AIXI
- Stock Information
- Founded
- RADX 2021
- AIXI 2001
- Country
- RADX Australia
- AIXI China
- Employees
- RADX N/A
- AIXI N/A
- Industry
- RADX
- AIXI Computer Software: Prepackaged Software
- Sector
- RADX
- AIXI Technology
- Exchange
- RADX NYSE
- AIXI Nasdaq
- Market Cap
- RADX 32.5M
- AIXI 31.2M
- IPO Year
- RADX N/A
- AIXI 2023
- Fundamental
- Price
- RADX $4.25
- AIXI $2.31
- Analyst Decision
- RADX Strong Buy
- AIXI
- Analyst Count
- RADX 2
- AIXI 0
- Target Price
- RADX $13.50
- AIXI N/A
- AVG Volume (30 Days)
- RADX 21.6K
- AIXI 138.1K
- Earning Date
- RADX 02-26-2025
- AIXI 05-15-2025
- Dividend Yield
- RADX N/A
- AIXI N/A
- EPS Growth
- RADX N/A
- AIXI N/A
- EPS
- RADX N/A
- AIXI N/A
- Revenue
- RADX $204,609.00
- AIXI $70,314,315.00
- Revenue This Year
- RADX N/A
- AIXI $26.84
- Revenue Next Year
- RADX N/A
- AIXI N/A
- P/E Ratio
- RADX N/A
- AIXI N/A
- Revenue Growth
- RADX N/A
- AIXI 18.84
- 52 Week Low
- RADX $3.50
- AIXI $2.06
- 52 Week High
- RADX $50.82
- AIXI $8.31
- Technical
- Relative Strength Index (RSI)
- RADX N/A
- AIXI 41.81
- Support Level
- RADX N/A
- AIXI $2.20
- Resistance Level
- RADX N/A
- AIXI $2.60
- Average True Range (ATR)
- RADX 0.00
- AIXI 0.31
- MACD
- RADX 0.00
- AIXI -0.01
- Stochastic Oscillator
- RADX 0.00
- AIXI 23.33
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.
About AIXI XIAO-I Corporation
XIAO-I Corp is an AI industrialization company focusing on the AI Cognitive Intelligence platform. The platform combines six core technologies including Natural Language Processing, Speech Processing, Computer Vision, Machine Learning, Affective Computing, Data Intelligence, and Hyper- automation. Based on the platform, The company developed products and solutions in the fields of Al+ Contact Center, Al+ Finance, Al+ City Public Service, Al+ Architecture, Al+ Metaverse, Al+ Manufacturing, and Al+ Healthcare. It generates revenue from the sale of software products and services, M&S services, and the sale of cloud platform products.